Fidelity Investments
VRCA icon

Fidelity Investments’s Verrica Pharmaceuticals VRCA Stock Holding History

Fidelity Investments’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,337
Closed -$14.4K – 5608
2025
Q3 		$14.4K Sell
3,337
-577
-15% -$3.48K ﹤0.01% 4492
2025
Q2 		$20.7K Buy
3,914
+2,353
+151% +$12.7K ﹤0.01% 4268
2025
Q1 		$6.9K Buy
1,561
+94
+6% +$608 ﹤0.01% 4603
2024
Q4 		$10.3K Sell
1,467
-61,964
-98% -$681K ﹤0.01% 4460
2024
Q3 		$920K Sell
63,431
-47,444
-43% -$2.14M ﹤0.01% 2626
2024
Q2 		$8.08M Sell
110,875
-40,050
-27% -$3.08M ﹤0.01% 1941
2024
Q1 		$8.93M Buy
150,925
+19
+0% +$1.05K ﹤0.01% 1908
2023
Q4 		$11M Buy
150,906
+434
+0.3% +$17.8K ﹤0.01% 1822
2023
Q3 		$5.85M Buy
150,472
+34,159
+29% +$1.74M ﹤0.01% 1997
2023
Q2 		$6.71M Sell
116,313
-19,782
-15% -$1.2M ﹤0.01% 1980
2023
Q1 		$8.85M Sell
136,095
-23,693
-15% -$1.43M ﹤0.01% 1920
2022
Q4 		$4.39M Sell
159,788
-18
-0% -$480 ﹤0.01% 2157
2022
Q3 		$4.67M Buy
159,806
+8
+0% +$274 ﹤0.01% 2198
2022
Q2 		$3.07M Buy
159,798
+95,243
+148% +$4.79M ﹤0.01% 2369
2022
Q1 		$5.24M Buy
64,555
+5
+0% +$412 ﹤0.01% 2357
2021
Q4 		$5.91M Buy
64,550
+40,855
+172% +$4.63M ﹤0.01% 2314
2021
Q3 		$2.96M Hold
23,695
– – ﹤0.01% 2487
2021
Q2 		$2.68M Hold
23,695
– – ﹤0.01% 2489
2021
Q1 		$3.59M Buy
23,695
+10,000
+73% +$1.38M ﹤0.01% 2346
2020
Q4 		$1.58M Sell
13,695
-10,763
-44% -$989K ﹤0.01% 2449
2020
Q3 		$1.89M Sell
24,458
-39,110
-62% -$3.2M ﹤0.01% 2320
2020
Q2 		$7M Hold
63,568
– – ﹤0.01% 1941
2020
Q1 		$6.95M Hold
63,568
– – ﹤0.01% 1818
2019
Q4 		$10.1M Buy
63,568
+1,005
+2% +$148K ﹤0.01% 1845
2019
Q3 		$9.23M Buy
62,563
+383
+0.6% +$42.7K ﹤0.01% 1865
2019
Q2 		$7.22M Hold
62,180
– – ﹤0.01% 1985
2019
Q1 		$6.72M Hold
62,180
– – ﹤0.01% 1991
2018
Q4 		$5.07M Sell
62,180
-2,360
-4% -$287K ﹤0.01% 2023
2018
Q3 		$10.5M Sell
64,540
-45,460
-41% -$7.76M ﹤0.01% 1918
2018
Q2 		$21.7M Buy
+110,000
New +$21.5M ﹤0.01% 1687

Other funds holding VRCA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments's VRCA Position: Q4 2025 in Review

Fidelity Investments sold out of Verrica Pharmaceuticals (VRCA) in Q4 2025, closing a stake of 3,337 shares — an estimated $14.4K sold.

Fidelity Investments first reported a position in VRCA in Q2 2018 and held it in 30 quarters. The position peaked at $21.7M in Q2 2018. 50 funds tracked by Wall St. Rank hold VRCA as of Q4 2025.

  • Fidelity Investments reported no remaining Verrica Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 3,337 Verrica Pharmaceuticals shares in Q4 2025, an estimated $14.4K.
  • Fidelity Investments first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 30 quarters.
  • Fidelity Investments's Verrica Pharmaceuticals position peaked at $21.7M in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.